CN116130117B - Access database-based method and device for realizing administration of anticoagulant drugs - Google Patents
Access database-based method and device for realizing administration of anticoagulant drugs Download PDFInfo
- Publication number
- CN116130117B CN116130117B CN202211590537.9A CN202211590537A CN116130117B CN 116130117 B CN116130117 B CN 116130117B CN 202211590537 A CN202211590537 A CN 202211590537A CN 116130117 B CN116130117 B CN 116130117B
- Authority
- CN
- China
- Prior art keywords
- drug
- current patient
- patient
- anticoagulant
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003146 anticoagulant agent Substances 0.000 title claims abstract description 125
- 238000000034 method Methods 0.000 title claims description 31
- 239000003814 drug Substances 0.000 claims abstract description 466
- 229940079593 drug Drugs 0.000 claims abstract description 268
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 132
- 208000024891 symptom Diseases 0.000 claims abstract description 113
- 230000010100 anticoagulation Effects 0.000 claims abstract description 106
- 238000004458 analytical method Methods 0.000 claims abstract description 59
- 230000000172 allergic effect Effects 0.000 claims abstract description 57
- 208000010668 atopic eczema Diseases 0.000 claims abstract description 57
- 238000007726 management method Methods 0.000 claims abstract description 40
- 238000012216 screening Methods 0.000 claims abstract description 28
- 201000010099 disease Diseases 0.000 claims description 49
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 49
- 230000000694 effects Effects 0.000 claims description 16
- 206010059866 Drug resistance Diseases 0.000 claims description 10
- 229940126585 therapeutic drug Drugs 0.000 claims description 9
- 230000004927 fusion Effects 0.000 claims description 6
- 206010020751 Hypersensitivity Diseases 0.000 claims description 5
- 208000026935 allergic disease Diseases 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 4
- 238000000556 factor analysis Methods 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 238000001647 drug administration Methods 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 15
- 238000004891 communication Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000004422 calculation algorithm Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000013473 artificial intelligence Methods 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 206010013700 Drug hypersensitivity Diseases 0.000 description 3
- 201000005311 drug allergy Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000007635 classification algorithm Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000000802 evaporation-induced self-assembly Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012847 principal component analysis method Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/22—Indexing; Data structures therefor; Storage structures
- G06F16/2291—User-Defined Types; Storage management thereof
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
- G06F16/20—Information retrieval; Database structures therefor; File system structures therefor of structured data, e.g. relational data
- G06F16/28—Databases characterised by their database models, e.g. relational or object models
- G06F16/284—Relational databases
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Engineering & Computer Science (AREA)
- Databases & Information Systems (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Software Systems (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention relates to a drug management technology, and discloses a management method for realizing anticoagulant drug administration based on an Access database, which comprises the following steps: analyzing the treatment symptoms of each drug in the anticoagulation drugs, classifying the anticoagulation drugs according to the treatment symptoms to obtain classified drugs, and constructing an Access database for managing the anticoagulation drugs; acquiring the illness symptoms of the current patient, analyzing the illness category of the current patient, and screening out the initial anticoagulation medicine conforming to the current patient from the classified medicines in the Access database according to the illness category; inquiring historical medical data of the current patient, extracting medical characteristics of the historical medical data, and analyzing allergic medicament factors of the current patient based on the medical characteristics; and carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs so as to screen out the final anticoagulation drugs which accord with the current patient from the initial anticoagulation drugs, and creating an anticoagulation drug management report of the current patient based on the final anticoagulation drugs. The invention aims at improving the rationality of anticoagulant medication management.
Description
Technical Field
The invention relates to the technical field of medicine management, in particular to a method and a device for realizing anticoagulant medicine administration based on an Access database.
Background
The anticoagulation medicine is a medicine commonly used for clinically preventing and treating thrombotic diseases, and the Access database is a relational database management system, so that the traditional management method has low efficiency because of various types and different effects of the anticoagulation medicines at present, and the anticoagulation medicine is managed in the form of the Access database at present, so that the management efficiency of the anticoagulation medicine is improved.
However, the current administration method of anticoagulant drugs is single, and by combining doctor's medical examination data and patient's medical examination data, the method does not consider the patient to take the diseases other than anticoagulant drug treatment, so that when the patient uses anticoagulant drugs and other drugs, drug conflict can occur, the treatment effect is not obvious, and the physical mechanism of the patient is seriously affected, so that a method capable of improving the rationality of anticoagulant drug administration is needed.
Disclosure of Invention
The invention provides a management method and a device for realizing anticoagulant medication based on an Access database, and mainly aims to improve the rationality of anticoagulant medication management.
In order to achieve the above purpose, the method for realizing the administration of anticoagulant drugs based on the Access database provided by the invention comprises the following steps:
obtaining anticoagulation medicines to be managed, analyzing treatment symptoms of each medicine in the anticoagulation medicines, classifying the anticoagulation medicines according to the treatment symptoms to obtain classified medicines, and constructing an Access database for managing the anticoagulation medicines according to the classified medicines;
receiving a medication request of the Access database, identifying a current patient corresponding to the medication request, determining the current illness state of the current patient, and inquiring the anticoagulation medicine type of the current patient according to the current illness state;
scheduling the historical medical data of the current patient, analyzing the historical disease category of the current patient according to the historical medical data, inquiring the treatment data of the historical disease category, and combining the treatment data and the historical disease category to obtain the administration drug category of the current patient;
and carrying out medicine conflict analysis on the anticoagulation medicine category and the administration medicine category to obtain an analysis result, inquiring medicine timeliness corresponding to the anticoagulation medicine category and the administration medicine category, and creating a medicine management scheme of the current patient by combining the medicine timeliness and the analysis result.
Optionally, the classifying the anticoagulant drug according to the therapeutic symptoms to obtain classified drugs includes:
acquiring parameters corresponding to each symptom in the treatment symptoms to obtain symptom parameters;
grading the treatment symptoms according to the symptom parameters to obtain symptom grades;
extracting the characteristics of the treatment symptoms to obtain characteristic symptoms;
setting a classification criterion of the anticoagulant drug according to the characteristic symptoms and the symptom grade;
and classifying the medicines in the anticoagulation medicines according to the classification criteria to obtain classified medicines.
Optionally, the constructing an Access database for managing the anticoagulant drug according to the classified drug includes:
extracting a drug identifier of each drug in the classified drugs;
according to the classified medicines, carrying out identification fusion on the medicine identifications to obtain target identifications;
carrying out semantic analysis on the target mark to obtain the mark semantic;
determining the medicine category of the classified medicine according to the identification semantics, and constructing a classifier of the classified medicine according to the medicine category;
detecting the medicine capacity of each medicine in the classified medicines, and creating a storage interval of the classified medicines according to the medicine capacity;
And generating an Access database for managing the anticoagulant drug according to the storage interval and the drug capacity.
Optionally, the analyzing the current patient's disease category based on the disease symptoms includes:
invoking a condition analysis report of the current patient;
inquiring the current patient's disease period according to the disease analysis report;
performing state detection on the current patient to obtain state information;
and combining the state information, the illness state period and the illness state symptoms to obtain the illness state type of the current patient.
Optionally, the screening the initial anticoagulation medicine conforming to the current patient from the classified medicines in the Access database according to the disease category comprises:
determining the name of the drug of the current patient according to the disease category, and acquiring clinical data of the current patient;
analyzing the drug resistance of the current patient based on the clinical data;
determining the drug dosage corresponding to the drug name according to the drug resistance;
and screening out initial anticoagulation medicines conforming to the current patient from the Access database according to the medicine names and the medicine dosages.
Optionally, the querying the historical medical data of the current patient includes:
acquiring patient information of the current patient, and calculating the weight of each piece of information in the patient information to obtain an information weight;
ordering the patient information according to the information weight to obtain an information sequence;
calculating the matching degree of the patient information and the patient data in a preset medical database according to the information sequence;
and dispatching the historical medical data of the current patient from the medical database according to the matching degree.
Optionally, the calculating the matching degree between the patient information and the patient data in the preset medical database includes:
calculating the matching degree of the patient information and the patient data in a preset medical database through the following formula:
wherein P represents the matching degree of patient information and patient data in a preset medical database, i represents the initial value of the patient data in the medical database, z represents the total number of patient information, and D a Vector value representing the a-th information in patient information, E b Represents the b-th patient data vector value in the medical database,representing the mean of the b-th patient data vector in the medical database.
Optionally, the analyzing the allergic drug factor of the current patient based on the medical feature includes:
determining a historical disease category for the current patient based on the medical characteristic;
inquiring the medicine category corresponding to the historical disease category, and determining the treatment medicine of the current patient according to the medicine category;
metering the dosage of the therapeutic drug, and screening allergic drugs in the therapeutic drug according to the dosage of the drug;
and carrying out composition factor analysis on the allergic medicament to obtain the allergic medicament factor of the current patient.
Optionally, the performing a drug property conflict analysis on each anticoagulant drug in the initial anticoagulant drugs according to the allergic drug factors to screen the final anticoagulant drugs conforming to the current patient from the initial anticoagulant drugs includes:
identifying a pharmaceutical composition of each of the initial anticoagulants;
extracting allergic medicinal components from the medicinal components according to the allergic factors;
detecting the drug activity of each drug in the allergic drug component;
according to the drug activity, carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs to obtain an analysis result;
And screening the final anticoagulant drug which accords with the current patient from the initial anticoagulant drug according to the analysis result.
An Access database-based management device for achieving anticoagulant medication, which is characterized by comprising:
the drug classification module is used for acquiring anticoagulants to be managed, analyzing treatment symptoms of each drug in the anticoagulants, classifying the anticoagulants according to the treatment symptoms to obtain classified drugs, and constructing an Access database for managing the anticoagulants according to the classified drugs;
the medicine screening module is used for acquiring the illness state symptoms of the current patient, analyzing the illness state category of the current patient based on the illness state symptoms, and screening the initial anticoagulation medicine conforming to the current patient from the Access database according to the illness state category;
the allergy analysis module is used for inquiring the historical medical data of the current patient, extracting medical features of the historical medical data and analyzing allergy medicament factors of the current patient based on the medical features;
and the scheme generation module is used for carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs according to the allergic drug factors so as to screen out the final anticoagulation drugs which accord with the current patient from the initial anticoagulation drugs, and creating an anticoagulation drug management report of the current patient based on the final anticoagulation drugs.
According to the invention, by acquiring the anticoagulation drugs to be managed and analyzing the treatment symptoms of each drug in the anticoagulation drugs, the treatment symptoms corresponding to each drug in the anticoagulation drugs can be obtained, so that the subsequent drug classification of the anticoagulation drugs is facilitated; in addition, according to the invention, the drug property conflict analysis is carried out on each anticoagulation drug in the initial anticoagulation drugs according to the allergic drug factors, so that the final anticoagulation drugs which accord with the current patient are screened out from the initial anticoagulation drugs, and the damage of drug allergy to the body functions of the current patient is avoided. Therefore, the method and the device for realizing the administration of the anticoagulant drug based on the Access database provided by the embodiment of the invention can improve the rationality of the administration management of the anticoagulant drug.
Drawings
Fig. 1 is a flow chart of a method for implementing anticoagulant medication based on an Access database according to an embodiment of the present application;
fig. 2 is a functional block diagram of a management device for implementing anticoagulant medication based on an Access database according to an embodiment of the present application;
fig. 3 is a schematic structural diagram of an electronic device for implementing the method for implementing anticoagulant medication based on Access database according to an embodiment of the present application.
The achievement of the objects, functional features and advantages of the present application will be further described with reference to the accompanying drawings, in conjunction with the embodiments.
Detailed Description
It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the application.
The embodiment of the application provides a management method for realizing anticoagulant medication based on an Access database. In the embodiment of the present application, the execution body of the method for implementing anticoagulant medication based on the Access database includes, but is not limited to, at least one of a server, a terminal, and other electronic devices capable of being configured to execute the method provided in the embodiment of the present application. In other words, the management method for implementing anticoagulant medication based on the Access database can be executed by software or hardware installed in a terminal device or a server device, and the software can be a blockchain platform. The service end includes but is not limited to: a single server, a server cluster, a cloud server or a cloud server cluster, and the like. The server may be an independent server, or may be a cloud server that provides cloud services, cloud databases, cloud computing, cloud functions, cloud storage, network services, cloud communications, middleware services, domain name services, security services, content delivery networks (Content Delivery Network, CDN), and basic cloud computing services such as big data and artificial intelligence platforms.
Referring to fig. 1, a flow chart of a management method for implementing anticoagulant medication based on an Access database according to an embodiment of the present invention is shown. In this embodiment, the method for implementing anticoagulant medication based on Access database includes steps S1-S4:
s1, obtaining anticoagulants to be managed, analyzing treatment symptoms of each of the anticoagulants, classifying the anticoagulants according to the treatment symptoms to obtain classified medicines, and constructing an Access database for managing the anticoagulants according to the classified medicines.
According to the invention, by acquiring the anticoagulants to be managed and analyzing the treatment symptoms of each of the anticoagulants, the treatment symptoms corresponding to each of the anticoagulants can be obtained, so that the anticoagulants can be conveniently classified later, wherein the anticoagulants are the medicine data for treating thrombotic diseases, the treatment symptoms are the disease states corresponding to each of the anticoagulants, and further, the treatment symptoms of each of the anticoagulants can be analyzed by combining clinical tests.
According to the invention, the anticoagulation medicines are classified according to the treatment symptoms to obtain classified medicines, so that the type of each medicine in the anticoagulation medicines can be known, and an Access database for managing the anticoagulation medicines can be constructed later, wherein the classified medicines are obtained after each medicine in the anticoagulation medicines is classified.
As one embodiment of the present invention, the classifying the anticoagulant drug according to the therapeutic symptoms to obtain classified drugs includes: obtaining parameters corresponding to each symptom in the treatment symptoms, obtaining symptom parameters, grading the treatment symptoms according to the symptom parameters, obtaining symptom grades, carrying out feature extraction on the treatment symptoms, obtaining feature symptoms, setting a classification criterion of the anticoagulation medicine according to the feature symptoms and the symptom grades, and carrying out medicine classification on the medicine in the anticoagulation medicine according to the classification criterion, so as to obtain classified medicine.
Wherein the symptom parameter is relevant information corresponding to the treatment symptom, such as a period of the symptom, a disease occurrence phenomenon and the like, the symptom grade represents the severity of the treatment symptom, such as early cancer, late cancer and the like, the characteristic symptom is representative symptom in the treatment symptom, and the classification criterion is a standard for classifying the anticoagulant drug.
Further, parameters corresponding to each symptom in the therapeutic symptoms can be obtained through a parameter extraction tool, the therapeutic symptoms can be classified according to the symptom periods in the symptom parameters, the feature extraction can be performed on the therapeutic symptoms through a genetic algorithm, the feature symptoms and the symptom grades can be used as classification rules, so that classification rules of the anticoagulant drugs are set, and the drugs in the anticoagulant drugs can be classified through the classification algorithms.
According to the invention, an Access database for managing the anticoagulation medicines is constructed according to the classified medicines, and the classified medicines can be classified and managed through the Access database so that corresponding medicines can be quickly found later, wherein the Access database is a database managed according to the types and the relations of the medicines.
As one embodiment of the present invention, the constructing an Access database for managing the anticoagulant drug according to the classified drug includes: extracting a medicine identifier of each medicine in the classified medicines, carrying out identifier fusion on the medicine identifiers according to the classified medicines to obtain target identifiers, carrying out semantic analysis on the target identifiers to obtain identifier semantics, determining medicine categories of the classified medicines according to the identifier semantics, constructing a classifier of the classified medicines according to the medicine categories, detecting medicine capacity of each medicine in the classified medicines, creating a storage interval of the classified medicines according to the medicine capacity, and generating an Access database for managing the anticoagulation medicines according to the storage interval and the medicine capacity.
The drug identification is a characteristic mark or a sign of each drug in the classified drugs, the target identification is obtained by weighting and fusing representative identifications in the drug identifications, the identification semantics are meanings corresponding to the target identifications, the drug categories are categories corresponding to the classified drugs, the classifier is used for automatically classifying the anticoagulated drugs, and the drug capacity represents the size of a storage space corresponding to the classified drugs.
Further, the drug identifier of each drug in the classified drugs can be extracted through an identifier extraction tool, the identifier extraction tool is compiled by a script language, the drug identifiers can be subjected to identifier fusion through a weighted fusion algorithm, semantic analysis can be performed on the target identifiers through a semantic analysis algorithm, the semantic analysis algorithm comprises a single-step algorithm, the drug category of the classified drugs can be determined through keywords in the identifier semantics, a storage section of the classified drugs can be created through a storage driver, and an Access database for managing the anticoagulation drugs can be generated through a storage server.
S2, acquiring the illness state symptoms of the current patient, analyzing the illness state category of the current patient based on the illness state symptoms, and screening out the initial anticoagulation medicine conforming to the current patient from the Access database according to the illness state category.
The invention facilitates the subsequent determination of anticoagulant drugs used by patients by acquiring the current patient's symptoms of the condition, wherein the symptoms of the condition are some phenomena caused by the current patient's condition.
According to the invention, the current illness state of the current patient is analyzed, so that the severity of the current illness state of the current patient is conveniently known, and the corresponding medicine can be better taken for treatment later, wherein the current illness state is the current illness state of the current patient.
As one embodiment of the present invention, the analyzing the current patient's disease category based on the disease symptoms includes: and calling a disease analysis report of the current patient, inquiring the disease period of the current patient according to the disease analysis report, carrying out state detection on the current patient to obtain state information, and combining the state information, the disease period and the disease symptoms to obtain the disease category of the current patient.
Wherein the condition analysis report is a result of a condition analysis of the current patient by a medical institution, the condition cycle is a duration of the current patient, and the status information is a status of a current physical status of the current patient.
Further, as an alternative embodiment of the present invention, the patient system of the medical institution may invoke a report of the patient's condition analysis, the symptom of the current patient may be determined by the symptom description of the medical institution in the report of the condition analysis, and the status information may be obtained by performing a physical examination or the like on the body of the current patient.
According to the invention, the anticoagulation medicine type of the current patient is inquired according to the current illness state, so that the current patient can be treated by the anticoagulation medicine in the follow-up process, wherein the anticoagulation medicine type is a specific type of the treatment medicine corresponding to the current illness state.
As one embodiment of the present invention, the screening the initial anticoagulant drug corresponding to the current patient from the Access database according to the disease category includes: determining the drug name of the current patient according to the disease category, acquiring clinical data of the current patient, analyzing the drug resistance of the current patient according to the clinical data, determining the drug dosage corresponding to the drug name according to the drug resistance, and classifying drugs from the Access database according to the drug name and the drug dosage to screen out initial anticoagulant drugs conforming to the current patient.
The clinical data are data of actual observation of the current patient, including daily examination and medication conditions, the drug resistance is that the current patient uses drugs for a long time, the drug dose is the corresponding dosage of the drug names, further, the disease symptoms of the current patient can be determined by inquiring the severity of the current disease, the clinical data of the current patient can be obtained by a medical system of the current patient, and the drug effect period of the current patient using the drugs can be analyzed to determine the drug resistance of the current patient.
S3, inquiring historical medical data of the current patient, extracting medical features of the historical medical data, and analyzing allergic medicament factors of the current patient based on the medical features.
According to the invention, the disease condition before the current patient can be known by inquiring the historical medical data of the current patient, so that the current medicine taking type of the current patient can be conveniently obtained later, wherein the historical medical data is related data of medical treatment before the current patient, and the historical disease is the disease suffered before the current patient.
As one embodiment of the present invention, the querying the historical medical data of the current patient includes: acquiring patient information of the current patient, calculating the weight of each piece of information in the patient information to obtain information weight, sorting the patient information according to the information weight to obtain an information sequence, calculating the matching degree of the patient information and patient data in a preset medical database according to the information sequence, and inquiring historical medical data of the current patient from the medical database according to the matching degree.
The patient information is information of the current patient, such as patient name, age, disease condition and the like, the information weight represents importance degree of each piece of information in the patient information, the information sequence is an order obtained by sorting the patient information according to numerical values of the information weights, the preset medical database is a database formed by all patients and corresponding medical data, and the matching degree is the matching degree of the patient information and the patient data in the medical database.
Further, as an optional embodiment of the present invention, the patient information of the current patient may be obtained through an extraction function, where the extraction function includes a left function, a weight of each piece of information in the patient information may be calculated through a weighted statistical method, semantic weights of the first semantic meaning and the second semantic meaning may be calculated through a fuzzy method, and the patient information may be ranked through a hil ranking method.
Further, as an optional embodiment of the present invention, the calculating the matching degree between the patient information and the patient data in the preset medical database includes:
calculating the matching degree of the patient information and the patient data in a preset medical database through the following formula:
wherein P represents the matching degree of patient information and patient data in a preset medical database, i represents the initial value of the patient data in the medical database, z represents the total number of patient information, and D a Vector value representing the a-th information in patient information, E b Represents the b-th patient data vector value in the medical database,representing the mean of the b-th patient data vector in the medical database.
According to the invention, the medical characteristics of the historical medical data are extracted, so that the characteristic data in the historical medical data can be known, the allergic medicament factors of the current patient can be conveniently analyzed later, and further, the medical characteristics of the historical medical data can be extracted through an HOG characteristic extraction algorithm.
According to the invention, the allergic medicament factor of the current patient is analyzed based on the medical characteristics, so that the subsequent medicament conflict analysis is facilitated, wherein the allergic medicament factor is the medicament factor causing allergy of the current patient.
As one embodiment of the present invention, the analyzing the allergic medication factor of the current patient based on the medical feature includes: according to the medical characteristics, determining the historical disease category of the current patient, inquiring the drug category corresponding to the historical disease category, determining the therapeutic drug of the current patient according to the drug category, measuring the drug dosage of the therapeutic drug, screening out the allergic drug in the therapeutic drug according to the drug dosage, and analyzing the composition factors of the allergic drug to obtain the allergic drug factors of the current patient.
The method comprises the steps of determining a history disease category of a current patient, determining a treatment drug category of the current patient, determining a drug dosage of the current patient, measuring the drug dosage of the treatment drug by a direct metering method, screening the allergic drug in the treatment drug by a screening function, and analyzing the composition factor of the allergic drug by a principal component analysis method.
S4, according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments so as to screen out a final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, and creating an anticoagulant medicament management report of the current patient based on the final anticoagulant medicaments.
According to the method, drug property conflict analysis is carried out on each anticoagulation drug in the initial anticoagulation drugs according to the allergic drug factors, so that the final anticoagulation drugs which accord with the current patient are screened out from the initial anticoagulation drugs, and the damage of drug allergy to the physical function of the current patient is avoided, wherein the final anticoagulation drugs are obtained after the drug property conflict analysis of the initial anticoagulation drugs.
As one embodiment of the present invention, the performing a drug property conflict analysis on each of the initial anticoagulants according to the allergic drug factor to screen the final anticoagulants conforming to the current patient from the initial anticoagulants includes: identifying the medicine components of each anticoagulant in the initial anticoagulants, extracting the allergic medicine components in the medicine components according to the allergic factors, detecting the medicine activity of each medicine in the allergic medicine components, carrying out medicine property conflict analysis on each anticoagulant in the initial anticoagulants according to the medicine activity to obtain an analysis result, and screening out the final anticoagulants which accord with the current patient from the initial anticoagulants according to the analysis result.
The medicine components are components of each anticoagulant in the initial anticoagulant, the allergic medicine components are components containing the allergic factors in the medicine components, the medicine activity is activity degree of each component in the allergic medicine components, further, the medicine components of each anticoagulant in the initial anticoagulant can be identified through a qualitative and quantitative analysis method, the medicine activity degree can be obtained through detecting the reaction intensity degree of the compound elements of each medicine in the allergic medicine components, and the medicine property conflict analysis can be carried out on each anticoagulant in the initial anticoagulant through a normal analysis method.
According to the invention, the anticoagulation medicine management report of the current patient is created based on the final anticoagulation medicine, so that the medication rationality of the current patient can be improved, and medicine conflict in the medication process is avoided, wherein the medicine timeliness is the action duration of the medicine, and the medication management scheme is a reasonable medication method for the current patient.
As one embodiment of the present invention, the creating an anticoagulant medication management report of the current patient based on the final anticoagulant medication includes: inquiring the medicine time effect of the final anticoagulation medicine, setting the medicine period of the final anticoagulation medicine, inquiring the medicine side effect of the final anticoagulation medicine, and creating a medicine management scheme of the current patient according to the medicine period and the medicine side effect.
The drug aging is the effective time of the final anticoagulation drug, the drug administration period is the drug administration time set according to the drug aging, the drug side effect is an adverse reaction generated by taking the final anticoagulation drug, and further, the drug administration scheme of the current patient can be created through a scheme generator.
According to the invention, by acquiring the anticoagulation drugs to be managed and analyzing the treatment symptoms of each drug in the anticoagulation drugs, the treatment symptoms corresponding to each drug in the anticoagulation drugs can be obtained, so that the subsequent drug classification of the anticoagulation drugs is facilitated; in addition, according to the invention, the drug property conflict analysis is carried out on each anticoagulation drug in the initial anticoagulation drugs according to the allergic drug factors, so that the final anticoagulation drugs which accord with the current patient are screened out from the initial anticoagulation drugs, and the damage of drug allergy to the body functions of the current patient is avoided. Therefore, the method for realizing the administration of the anticoagulant drug based on the Access database provided by the embodiment of the invention can improve the rationality of the administration management of the anticoagulant drug.
Fig. 2 is a functional block diagram of a management device for implementing anticoagulant medication based on an Access database according to an embodiment of the present invention.
The management device 100 for realizing anticoagulant medication based on Access database can be installed in electronic equipment. According to the implemented functions, the management device 100 for implementing anticoagulant medication based on Access database may include a medication classification module 101, a medication analysis module 102, a disease analysis module 103, and a solution generation module 104. The module of the invention, which may also be referred to as a unit, refers to a series of computer program segments, which are stored in the memory of the electronic device, capable of being executed by the processor of the electronic device and of performing a fixed function.
In the present embodiment, the functions concerning the respective modules/units are as follows:
the medicine classification module 101 is configured to obtain anticoagulants to be managed, analyze treatment symptoms of each medicine in the anticoagulants, classify the anticoagulants according to the treatment symptoms to obtain classified medicines, and construct an Access database for managing the anticoagulants according to the classified medicines;
the drug analysis module 102 is configured to obtain a disease symptom of a current patient, analyze a disease category of the current patient based on the disease symptom, and screen out an initial anticoagulation drug conforming to the current patient from the Access database according to the disease category;
The disease analysis module 103 is configured to query historical medical data of the current patient, extract medical features of the historical medical data, and analyze allergic medicament factors of the current patient based on the medical features;
the solution generating module 104 is configured to perform a drug property conflict analysis on each anticoagulant drug in the initial anticoagulant drugs according to the allergic drug factors, so as to screen a final anticoagulant drug that meets the current patient from the initial anticoagulant drugs, and create an anticoagulant drug management report of the current patient based on the final anticoagulant drug.
In detail, each module in the device 100 for implementing anticoagulant medication based on Access database in the embodiment of the present application adopts the same technical means as the method for implementing anticoagulant medication based on Access database described in fig. 1, and can produce the same technical effects, which are not described herein.
Fig. 3 is a schematic structural diagram of an electronic device 1 for implementing a management method for anticoagulant medication based on an Access database according to an embodiment of the present application.
The electronic device 1 may comprise a processor 10, a memory 11, a communication bus 12 and a communication interface 13, and may further comprise a computer program stored in the memory 11 and executable on the processor 10, such as a management method program for implementing anticoagulant medication based on an Access database.
The processor 10 may be formed by an integrated circuit in some embodiments, for example, a single packaged integrated circuit, or may be formed by a plurality of integrated circuits packaged with the same function or different functions, including one or more central processing units (Central Processing Unit, CPU), a microprocessor, a digital processing chip, a graphics processor, a combination of various control chips, and so on. The processor 10 is a Control Unit (Control Unit) of the electronic device 1, connects respective parts of the entire electronic device using various interfaces and lines, executes or executes programs or modules stored in the memory 11 (for example, executes a management method program for implementing anticoagulant medication based on an Access database, etc.), and invokes data stored in the memory 11 to perform various functions of the electronic device and process data.
The memory 11 includes at least one type of readable storage medium including flash memory, a removable hard disk, a multimedia card, a card type memory (e.g., SD or DX memory, etc.), a magnetic memory, a magnetic disk, an optical disk, etc. The memory 11 may in some embodiments be an internal storage unit of the electronic device, such as a mobile hard disk of the electronic device. The memory 11 may in other embodiments also be an external storage device of the electronic device, such as a plug-in mobile hard disk, a Smart Media Card (SMC), a Secure Digital (SD) Card, a Flash memory Card (Flash Card) or the like, which are provided on the electronic device. Further, the memory 11 may also include both an internal storage unit and an external storage device of the electronic device. The memory 11 may be used not only to store application software installed in an electronic device and various data, such as codes of a management method program for implementing anticoagulant medication based on an Access database, but also to temporarily store data that has been output or is to be output.
The communication bus 12 may be a peripheral component interconnect standard (Peripheral Component Interconnect, PCI) bus, or an extended industry standard architecture (Extended Industry Standard Architecture, EISA) bus, among others. The bus may be classified as an address bus, a data bus, a control bus, etc. The bus is arranged to enable a connection communication between the memory 11 and at least one processor 10 etc.
The communication interface 13 is used for communication between the electronic device 1 and other devices, including a network interface and a user interface. Optionally, the network interface may include a wired interface and/or a wireless interface (e.g., WI-FI interface, bluetooth interface, etc.), typically used to establish a communication connection between the electronic device and other electronic devices. The user interface may be a Display (Display), an input unit such as a Keyboard (Keyboard), or alternatively a standard wired interface, a wireless interface. Alternatively, in some embodiments, the display may be an LED display, a liquid crystal display, a touch-sensitive liquid crystal display, an OLED (Organic Light-Emitting Diode) touch, or the like. The display may also be referred to as a display screen or display unit, as appropriate, for displaying information processed in the electronic device and for displaying a visual user interface.
Fig. 3 shows only an electronic device with components, it being understood by a person skilled in the art that the structure shown in fig. 3 does not constitute a limitation of the electronic device 1, and may comprise fewer or more components than shown, or may combine certain components, or may be arranged in different components.
For example, although not shown, the electronic device 1 may further include a power source (such as a battery) for supplying power to each component, and preferably, the power source may be logically connected to the at least one processor 10 through a power management device, so that functions of charge management, discharge management, power consumption management, and the like are implemented through the power management device. The power supply may also include one or more of any of a direct current or alternating current power supply, recharging device, power failure detection circuit, power converter or inverter, power status indicator, etc. The electronic device 1 may further include various sensors, bluetooth modules, wi-Fi modules, etc., which will not be described herein.
It should be understood that the embodiments described are for illustrative purposes only and are not limited to this configuration in the scope of the patent application.
The management method program for implementing anticoagulant medication based on Access database stored in the memory 11 of the electronic device 1 is a combination of a plurality of instructions, and when running in the processor 10, it can implement:
Obtaining anticoagulation medicines to be managed, analyzing treatment symptoms of each medicine in the anticoagulation medicines, classifying the anticoagulation medicines according to the treatment symptoms to obtain classified medicines, and constructing an Access database for managing the anticoagulation medicines according to the classified medicines;
acquiring the illness symptoms of a current patient, analyzing the illness category of the current patient based on the illness symptoms, and screening out an initial anticoagulation medicament conforming to the current patient from the Access database according to the illness category;
inquiring historical medical data of the current patient, extracting medical characteristics of the historical medical data, and analyzing allergic medicament factors of the current patient based on the medical characteristics;
and according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments so as to screen out a final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, and creating an anticoagulant medicament management report of the current patient based on the final anticoagulant medicaments.
In particular, the specific implementation method of the above instructions by the processor 10 may refer to the description of the relevant steps in the corresponding embodiment of the drawings, which is not repeated herein.
Further, the modules/units integrated in the electronic device 1 may be stored in a computer readable storage medium if implemented in the form of software functional units and sold or used as separate products. The computer readable storage medium may be volatile or nonvolatile. For example, the computer readable medium may include: any entity or device capable of carrying the computer program code, a recording medium, a U disk, a removable hard disk, a magnetic disk, an optical disk, a computer Memory, a Read-Only Memory (ROM).
The present invention also provides a computer readable storage medium storing a computer program which, when executed by a processor of an electronic device, can implement:
obtaining anticoagulation medicines to be managed, analyzing treatment symptoms of each medicine in the anticoagulation medicines, classifying the anticoagulation medicines according to the treatment symptoms to obtain classified medicines, and constructing an Access database for managing the anticoagulation medicines according to the classified medicines;
acquiring the illness symptoms of a current patient, analyzing the illness category of the current patient based on the illness symptoms, and screening out an initial anticoagulation medicament conforming to the current patient from the Access database according to the illness category;
Inquiring historical medical data of the current patient, extracting medical characteristics of the historical medical data, and analyzing allergic medicament factors of the current patient based on the medical characteristics;
and according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments so as to screen out a final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, and creating an anticoagulant medicament management report of the current patient based on the final anticoagulant medicaments.
In the several embodiments provided in the present invention, it should be understood that the disclosed apparatus, device and method may be implemented in other manners. For example, the above-described apparatus embodiments are merely illustrative, and for example, the division of the modules is merely a logical function division, and there may be other manners of division when actually implemented.
The modules described as separate components may or may not be physically separate, and components shown as modules may or may not be physical units, may be located in one place, or may be distributed over multiple network units. Some or all of the modules may be selected according to actual needs to achieve the purpose of the solution of this embodiment.
In addition, each functional module in the embodiments of the present application may be integrated in one processing unit, or each unit may exist alone physically, or two or more units may be integrated in one unit. The integrated units can be realized in a form of hardware or a form of hardware and a form of software functional modules.
It will be evident to those skilled in the art that the application is not limited to the details of the foregoing illustrative embodiments, and that the present application may be embodied in other specific forms without departing from the spirit or essential characteristics thereof.
The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, the scope of the application being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Any reference signs in the claims shall not be construed as limiting the claim concerned.
The embodiment of the application can acquire and process the related data based on the artificial intelligence technology. Among these, artificial intelligence (Artificial Intelligence, AI) is the theory, method, technique and application system that uses a digital computer or a digital computer-controlled machine to simulate, extend and extend human intelligence, sense the environment, acquire knowledge and use knowledge to obtain optimal results.
Furthermore, it is evident that the word "comprising" does not exclude other elements or steps, and that the singular does not exclude a plurality. A plurality of units or means recited in the system claims can also be implemented by means of software or hardware by means of one unit or means. The terms first, second, etc. are used to denote a name, but not any particular order.
Finally, it should be noted that the above-mentioned embodiments are merely for illustrating the technical solution of the present invention and not for limiting the same, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications and equivalents may be made to the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention.
Claims (3)
1. The method for realizing the administration of anticoagulant drugs based on the Access database is characterized by comprising the following steps:
obtaining anticoagulation medicines to be managed, analyzing treatment symptoms of each medicine in the anticoagulation medicines, classifying the anticoagulation medicines according to the treatment symptoms to obtain classified medicines, and constructing an Access database for managing the anticoagulation medicines according to the classified medicines;
the step of classifying the anticoagulant drugs according to the treatment symptoms to obtain classified drugs, comprising:
Acquiring parameters corresponding to each symptom in the treatment symptoms to obtain symptom parameters;
grading the treatment symptoms according to the symptom parameters to obtain symptom grades;
extracting the characteristics of the treatment symptoms to obtain characteristic symptoms;
setting a classification criterion of the anticoagulant drug according to the characteristic symptoms and the symptom grade;
according to the classification criteria, classifying the medicines in the anticoagulation medicines to obtain classified medicines;
the constructing an Access database for managing the anticoagulant drug according to the classified drug comprises the following steps:
extracting a drug identifier of each drug in the classified drugs;
according to the classified medicines, carrying out identification fusion on the medicine identifications to obtain target identifications;
carrying out semantic analysis on the target mark to obtain mark semantics;
determining the medicine category of the classified medicine according to the identification semantics, and constructing a classifier of the classified medicine according to the medicine category;
detecting the medicine capacity of each medicine in the classified medicines, and creating a storage interval of the classified medicines according to the medicine capacity;
generating an Access database for managing the anticoagulant according to the storage interval and the medicine capacity;
Acquiring the illness symptoms of a current patient, analyzing the illness category of the current patient based on the illness symptoms, and screening out an initial anticoagulation medicament conforming to the current patient from the Access database according to the illness category;
screening out initial anticoagulant drugs conforming to the current patient from the Access database, wherein the screening comprises the following steps:
determining the name of the drug of the current patient according to the disease category, and acquiring clinical data of the current patient;
analyzing the drug resistance of the current patient based on the clinical data;
determining the drug dosage corresponding to the drug name according to the drug resistance;
classifying medicines from the Access database according to the medicine names and the medicine dosages, and screening initial anticoagulation medicines conforming to the current patient;
inquiring historical medical data of the current patient, extracting medical characteristics of the historical medical data, and analyzing allergic medicament factors of the current patient based on the medical characteristics;
the querying the historical medical data of the current patient includes:
acquiring patient information of the current patient, and calculating the weight of each piece of information in the patient information to obtain an information weight;
Ordering the patient information according to the information weight to obtain an information sequence;
calculating the matching degree of the patient information and the patient data in a preset medical database according to the information sequence;
scheduling historical medical data of the current patient from the medical database according to the matching degree;
the calculating the matching degree of the patient information and the patient data in the preset medical database comprises the following steps:
calculating the matching degree of the patient information and the patient data in a preset medical database through the following formula:
wherein (1)>Representing the matching degree of patient information and patient data in a preset medical database, i representing the initial value of the patient data in the medical database,/for>Representing the total number of patient information>Vector value representing the a-th information of patient information, a->Representing the b-th patient data vector value in the medical database,/->Representing a b-th patient data vector mean in the medical database;
the analyzing the allergic medication factor of the current patient based on the medical characteristic includes:
determining a historical disease category for the current patient based on the medical characteristic;
inquiring the medicine category corresponding to the historical disease category, and determining the treatment medicine of the current patient according to the medicine category;
Metering the dosage of the therapeutic drug, and screening allergic drugs in the therapeutic drug according to the dosage of the drug;
carrying out composition factor analysis on the allergic medicament to obtain allergic medicament factors of the current patient;
according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments to screen out a final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, and creating an anticoagulant medicament management report of the current patient based on the final anticoagulant medicament;
and according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments so as to screen out the final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, wherein the medicament property conflict analysis comprises the following steps:
identifying a pharmaceutical composition of each of the initial anticoagulants;
extracting allergic medicament components from the medicament components according to the allergic medicament factors;
detecting the drug activity of each drug in the allergic drug component;
according to the drug activity, carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs to obtain an analysis result;
And screening the final anticoagulant drug which accords with the current patient from the initial anticoagulant drug according to the analysis result.
2. The Access database-based management method for anticoagulant medication according to claim 1, wherein the analyzing the current patient's disease category based on the disease symptoms comprises:
invoking a condition analysis report of the current patient;
inquiring the current patient's disease period according to the disease analysis report;
performing state detection on the current patient to obtain state information;
and combining the state information, the illness state period and the illness state symptoms to obtain the illness state type of the current patient.
3. An Access database-based management device for achieving anticoagulant medication, which is characterized by comprising:
the drug classification module is used for acquiring anticoagulants to be managed, analyzing treatment symptoms of each drug in the anticoagulants, classifying the anticoagulants according to the treatment symptoms to obtain classified drugs, and constructing an Access database for managing the anticoagulants according to the classified drugs;
the step of classifying the anticoagulant drugs according to the treatment symptoms to obtain classified drugs, comprising:
Acquiring parameters corresponding to each symptom in the treatment symptoms to obtain symptom parameters;
grading the treatment symptoms according to the symptom parameters to obtain symptom grades;
extracting the characteristics of the treatment symptoms to obtain characteristic symptoms;
setting a classification criterion of the anticoagulant drug according to the characteristic symptoms and the symptom grade;
according to the classification criteria, classifying the medicines in the anticoagulation medicines to obtain classified medicines;
the constructing an Access database for managing the anticoagulant drug according to the classified drug comprises the following steps:
extracting a drug identifier of each drug in the classified drugs;
according to the classified medicines, carrying out identification fusion on the medicine identifications to obtain target identifications;
carrying out semantic analysis on the target mark to obtain mark semantics;
determining the medicine category of the classified medicine according to the identification semantics, and constructing a classifier of the classified medicine according to the medicine category;
detecting the medicine capacity of each medicine in the classified medicines, and creating a storage interval of the classified medicines according to the medicine capacity;
generating an Access database for managing the anticoagulant according to the storage interval and the medicine capacity;
The medicine screening module is used for acquiring the illness state symptoms of the current patient, analyzing the illness state category of the current patient based on the illness state symptoms, and screening the initial anticoagulation medicine conforming to the current patient from the Access database according to the illness state category;
screening out initial anticoagulant drugs conforming to the current patient from the Access database, wherein the screening comprises the following steps:
determining the name of the drug of the current patient according to the disease category, and acquiring clinical data of the current patient;
analyzing the drug resistance of the current patient based on the clinical data;
determining the drug dosage corresponding to the drug name according to the drug resistance;
classifying medicines from the Access database according to the medicine names and the medicine dosages, and screening initial anticoagulation medicines conforming to the current patient;
the allergy analysis module is used for inquiring the historical medical data of the current patient, extracting medical features of the historical medical data and analyzing allergy medicament factors of the current patient based on the medical features;
the querying the historical medical data of the current patient includes:
Acquiring patient information of the current patient, and calculating the weight of each piece of information in the patient information to obtain an information weight;
ordering the patient information according to the information weight to obtain an information sequence;
calculating the matching degree of the patient information and the patient data in a preset medical database according to the information sequence;
scheduling historical medical data of the current patient from the medical database according to the matching degree;
the calculating the matching degree of the patient information and the patient data in the preset medical database comprises the following steps:
calculating the matching degree of the patient information and the patient data in a preset medical database through the following formula:
wherein (1)>Representing the matching degree of patient information and patient data in a preset medical database, i representing the initial value of the patient data in the medical database,/for>Representing the total number of patient information>Vector value representing the a-th information of patient information, a->Representing the b-th patient data vector value in the medical database,/->Representing a b-th patient data vector mean in the medical database;
the analyzing the allergic medication factor of the current patient based on the medical characteristic includes:
Determining a historical disease category for the current patient based on the medical characteristic;
inquiring the medicine category corresponding to the historical disease category, and determining the treatment medicine of the current patient according to the medicine category;
metering the dosage of the therapeutic drug, and screening allergic drugs in the therapeutic drug according to the dosage of the drug;
carrying out composition factor analysis on the allergic medicament to obtain allergic medicament factors of the current patient;
the scheme generation module is used for carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs according to the allergic drug factors so as to screen out a final anticoagulation drug which accords with the current patient from the initial anticoagulation drugs, and creating an anticoagulation drug management report of the current patient based on the final anticoagulation drugs;
and according to the allergic medicament factors, performing medicament property conflict analysis on each anticoagulant medicament in the initial anticoagulant medicaments so as to screen out the final anticoagulant medicament conforming to the current patient from the initial anticoagulant medicaments, wherein the medicament property conflict analysis comprises the following steps:
identifying a pharmaceutical composition of each of the initial anticoagulants;
extracting allergic medicament components from the medicament components according to the allergic medicament factors;
Detecting the drug activity of each drug in the allergic drug component;
according to the drug activity, carrying out drug property conflict analysis on each anticoagulation drug in the initial anticoagulation drugs to obtain an analysis result;
and screening the final anticoagulant drug which accords with the current patient from the initial anticoagulant drug according to the analysis result.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211590537.9A CN116130117B (en) | 2022-12-12 | 2022-12-12 | Access database-based method and device for realizing administration of anticoagulant drugs |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211590537.9A CN116130117B (en) | 2022-12-12 | 2022-12-12 | Access database-based method and device for realizing administration of anticoagulant drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116130117A CN116130117A (en) | 2023-05-16 |
| CN116130117B true CN116130117B (en) | 2023-11-03 |
Family
ID=86301856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211590537.9A Active CN116130117B (en) | 2022-12-12 | 2022-12-12 | Access database-based method and device for realizing administration of anticoagulant drugs |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116130117B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109243546A (en) * | 2018-09-07 | 2019-01-18 | 上海交通大学医学院附属新华医院 | The method for building up and device of anticoagulation drug effect Optimized model |
| CN110797103A (en) * | 2019-10-28 | 2020-02-14 | 重庆亚德科技股份有限公司 | Reasonable medicine-taking monitoring system |
| CN112116978A (en) * | 2020-09-17 | 2020-12-22 | 陕西师范大学 | Method, system and device for recommending rheumatism immunity medicine |
| CN112700838A (en) * | 2020-12-30 | 2021-04-23 | 平安科技（深圳）有限公司 | Big data-based medication scheme recommendation method and device and related equipment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200027555A1 (en) * | 2018-07-17 | 2020-01-23 | Lewis Pharmaceutical Information, Inc. | Patient centric drug analysis platform |
| US20200395114A1 (en) * | 2019-06-13 | 2020-12-17 | Avinash Bachwani | Algorithmic Method to Detect Discrepancies in Electronic Medication Histories |
-
2022
- 2022-12-12 CN CN202211590537.9A patent/CN116130117B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109243546A (en) * | 2018-09-07 | 2019-01-18 | 上海交通大学医学院附属新华医院 | The method for building up and device of anticoagulation drug effect Optimized model |
| CN110797103A (en) * | 2019-10-28 | 2020-02-14 | 重庆亚德科技股份有限公司 | Reasonable medicine-taking monitoring system |
| CN112116978A (en) * | 2020-09-17 | 2020-12-22 | 陕西师范大学 | Method, system and device for recommending rheumatism immunity medicine |
| CN112700838A (en) * | 2020-12-30 | 2021-04-23 | 平安科技（深圳）有限公司 | Big data-based medication scheme recommendation method and device and related equipment |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116130117A (en) | 2023-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8285734B2 (en) | Comparison of documents based on similarity measures | |
| KR101450784B1 (en) | Systematic identification method of novel drug indications using electronic medical records in network frame method | |
| CN112216361A (en) | Follow-up plan list generation method, device, terminal and medium based on artificial intelligence | |
| CN113707303A (en) | Method, device, equipment and medium for solving medical problems based on knowledge graph | |
| EP3382584A1 (en) | A system and a method to predict patient behaviour | |
| CN112614578B (en) | Doctor intelligent recommendation method and device, electronic equipment and storage medium | |
| CN111066033A (en) | Machine learning method for generating labels of fuzzy results | |
| CN111223571A (en) | Adverse drug reaction monitoring method and device, computer equipment and storage medium | |
| Zhao et al. | Handling temporality of clinical events for drug safety surveillance | |
| CN114612194A (en) | Product recommendation method and device, electronic equipment and storage medium | |
| Yu et al. | Clinical coverage of an archetype repository over SNOMED-CT | |
| CN114220541A (en) | Disease prediction method, disease prediction device, electronic device, and storage medium | |
| CN111933246B (en) | Medical prescription analysis method, system, electronic device and storage medium | |
| CN112530602A (en) | Method and device for analyzing side effect of medicine, electronic equipment and computer storage medium | |
| CN113744845A (en) | Medical image processing method, device, equipment and medium based on artificial intelligence | |
| CN116130117B (en) | Access database-based method and device for realizing administration of anticoagulant drugs | |
| CN116524995A (en) | Medicine curative effect prediction method based on artificial intelligence and related equipment | |
| CN112258135A (en) | Method and device for auditing prescription data and computer-readable storage medium | |
| CN116719891A (en) | Clustering method, device, equipment and computer storage medium for traditional Chinese medicine information packet | |
| CN116486982A (en) | Auxiliary generation method and device for AI doctor advice | |
| CN113689924B (en) | Similar medical record retrieval method and device, electronic equipment and readable storage medium | |
| CN115775635A (en) | Medicine risk identification method and device based on deep learning model and terminal equipment | |
| CN115631823A (en) | Similar case recommendation method and system | |
| CN114864094A (en) | Intensive care unit intelligent control method, equipment and medium | |
| CN114841165A (en) | User data analysis and display method and device, electronic equipment and storage medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |